Assertio provides response to letter from short-seller

Claims about rolvedon and assertio's accounting practices are false and baseless short-seller's press release is another improper attempt to enrich himself at assertio's expense company considering taking legal and regulatory action lake forest, ill., nov. 11, 2024 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today issued the following letter from chief executive officer brendan o'grady in response to public comments made november 8, 2024 by a short-seller: to the members of the investment community, as many of you have been aware, mr.
ASRT Ratings Summary
ASRT Quant Ranking